Literature DB >> 1169135

Standards for total serum protein assays--a collaborative study.

B T Doumas.   

Abstract

We have studied the standardization of total serum protein assay with the biuret reaction. Standard solutions were prepared from lyophilized preparations of human serum albumin and bovine serum albumin, with corrections made for volatile material and ash contents. These solutions and a solution of crystalline albumin standard were analyzed with a new stable biuret reagent, to establish absorptivity values (values for the absorbance of a 1 g/liter final reaction mixture). The mean values obtained were 0.302, 0.292, and 0.290 for human serum albumin, bovine serum albumin, and the crystalline albumin, respectively. We believe that the established absorptivity value will improve the accuracy of serum protein determinations. We studied the linearity of the relation between color produced and protein concentration, with use of the solutions described above and a serum pool. The color adheres to Beer's law up to the highest concentration tested: 3 g/liter for HSA and BSA, and 2.8 g/liter for serum in the final reaction mixture. The new biuret reagent has been stable for one year at room temperature. We recommend the use of bovine serum albumin as a primary standard for serum protein assays. It is inexpensive, easily available, and exhibits the best linearity in the biuret reaction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1169135

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  43 in total

1.  Paraprotein estimation: a comparison of immunochemical and densitometric techniques.

Authors:  A M Smith; R A Thompson
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

2.  Blood volume and body fluid compartments in lambs with aortopulmonary left-to-right shunts.

Authors:  J W Gratama; M Dalinghaus; J J Meuzelaar; A M Gerding; J H Koers; W G Zijlstra; J R Kuipers
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  Level and period of realimentation to assess improvement in body condition and carcass quality in cull ewes.

Authors:  Randhir Singh Bhatt; Nira Manik Soren; Artabandhu Sahoo; Shaikh Abdul Karim
Journal:  Trop Anim Health Prod       Date:  2012-05-29       Impact factor: 1.559

4.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

5.  Effect of concentrate supplementation on performance, ovarian response, and some biochemical profile of Malpura ewes.

Authors:  S M K Naqvi; N M Soren; S A Karim
Journal:  Trop Anim Health Prod       Date:  2011-02-02       Impact factor: 1.559

6.  Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.

Authors:  R Gavioli; M G Kurilla; P O de Campos-Lima; L E Wallace; R Dolcetti; R J Murray; A B Rickinson; M G Masucci
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

7.  ELISA and some biochemical tests of heterophyidae infection in laboratory animals.

Authors:  Mahmoud A El-Seify; Nasr M El-Bahy; Abdelrazek Y Desouky; Eman K Bazh
Journal:  Parasitol Res       Date:  2011-07-21       Impact factor: 2.289

8.  Neuromuscular and hormonal responses in elite athletes to two successive strength training sessions in one day.

Authors:  K Häkkinen; A Pakarinen; M Alén; H Kauhanen; P V Komi
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

9.  Ligand-binding properties of proalbumin Christchurch.

Authors:  R G Reed; T Peters; S O Brennan; R W Carrell
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

10.  A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.

Authors:  S M Morgan; G W Wilkinson; E Floettmann; N Blake; A B Rickinson
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.